New microscope could help surgeons remove all prostate cancer in one go

NCT ID NCT07516808

Not yet recruiting Diagnosis Sponsor: Beth Israel Deaconess Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special microscope that lets surgeons check for leftover cancer cells right after removing the prostate. It involves 20 men with prostate cancer who are already scheduled for surgery. The goal is to see if the microscope can accurately find cancer at the edges of the removed tissue, helping surgeons remove any remaining cancer during the same operation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nonlinear microscope (NLM) imaging device
What this could lead to: If successful, this could help surgeons remove all cancer during prostate surgery, potentially reducing the need for follow-up treatments.
What could go wrong: This is a very small, early feasibility study with only 20 participants. The device may not be accurate enough or practical for routine use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Beth Israel Deaconess Medical Center (BIDMC)

Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.